GlucoFit

We listen to patients. Usually, therapy does not go optimal. We are asking why.

From these answers we develop a smart, fast and human-centered solution. We apply modern methods from service design and application development together with an agile mindset to help to digitize a therapy in a sector with still much more potential of digitalization

In the center of GlucoFit stands a companion app and decision support system for patients with type 1 diabetes. A lot of data is available on continuous glucose measurement. But in everyday life, patients find it difficult to derive decisions from this data. We use artificial intelligence to create an individualized therapy while interconnection digital with classical therapy through the involvement of the treating physicians.

We are two physicist (quantum information theory) knowing each other from uni research times many years ago.

Inka Benthin, CEO, has collected extensive experience in managing complex IT-programs with multi million euro budget (Capgemini), Dr. Matthias Ohliger, CTO, in developing corporate strategies for digital transformations of world leading companies (PwC, Bain& Company). With Inka Benthin as type-1 herself and using GlucoFit everyday, key-user knowledge is in the team. In an earlier life we both have worked hands-on as software developers.

So, we know the technology, we know the need and we know how to make things happen.

We will extend our team 2022 by an expert in health sector with focus on business growth.